Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1

Interventions

pembrolizumab 250 Nivolumab 144 Cisplatin 138 Cyclophosphamide 137 Paclitaxel 116 Carboplatin 112 Gemcitabine 100 Radiotherapy 86 Dexamethasone 84 Docetaxel 79 Ipilimumab 70 atezolizumab 68 Doxorubicin 63 Fluorouracil 60 Blood Specimen Collection 60 Bevacizumab 59 Etoposide 55 fludarabine 54 Rituximab 54 Oxaliplatin 52 Prednisone 51 Lenalidomide 51 Surveys and Questionnaires 50 Cetuximab 47 Standard of Care 46 Capecitabine 46 Radiosurgery 45 Magnetic Resonance Spectroscopy 45 lenvatinib 43 durvalumab 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × darlin protein, Dictyostelium × 1 year × Clear all

NCT03180736 2025-12-19

EMN14

European Myeloma Network B.V.

Phase 3 Completed

304 enrolled 19 charts 1 FDA

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡